ArticleCancer immunology, immunotherapy : CII2025

A matrix stiffness gene signature identifies SLC20A1 as a novel mechano-immunological checkpoint enabling synergistic immunotherapy in pancreatic ductal adenocarcinoma.

Chuanbing Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.